Aquestive Therapeutics, Inc. AQST Increase (Decrease) in Accounts and Other Receivables
Increase (Decrease) in Accounts and Other Receivables at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsAndOtherReceivables.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s increase (decrease) in accounts and other receivables.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s increase (decrease) in accounts and other receivables?
- Aquestive Therapeutics, Inc. (AQST) reported increase (decrease) in accounts and other receivables of -$10.9M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s increase (decrease) in accounts and other receivables changed year-over-year?
- Aquestive Therapeutics, Inc.'s increase (decrease) in accounts and other receivables decreased by 448.2% year-over-year, from $3.13M to -$10.9M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s increase (decrease) in accounts and other receivables?
- Over 2 years (2022 to 2025), Aquestive Therapeutics, Inc.'s increase (decrease) in accounts and other receivables has grown at a 19.1% compound annual growth rate (CAGR), from -$7.35M to $10.44M.